RG
Redmile Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-489,208
| Closed | -$42.4M | – | 69 |
|
|
2023
Q2 | $42.4M | Buy |
489,208
+154,038
| +46% | +$13.4M | 1.63% | 18 |
|
|
2023
Q1 | $32.6M | Buy |
+335,170
| New | +$32.6M | 1.41% | 24 |
|
|
2022
Q3 | – | Sell |
-300,000
| Closed | -$24.9M | – | 71 |
|
|
2022
Q2 | $24.9M | Buy |
+300,000
| New | +$24.9M | 0.95% | 30 |
|
|
2019
Q3 | – | Sell |
-97,191
| Closed | -$8.32M | – | 76 |
|
|
2019
Q2 | $8.32M | Buy |
+97,191
| New | +$8.32M | 0.24% | 60 |
|
|
2018
Q1 | – | Sell |
-2,500
| Closed | -$223K | – | 67 |
|
|
2017
Q4 | $223K | Buy |
+2,500
| New | +$223K | 0.01% | 67 |
|
|
2016
Q3 | – | Sell |
-322,394
| Closed | -$25.1M | – | 53 |
|
|
2016
Q2 | $25.1M | Sell |
322,394
-155,893
| -33% | -$12.1M | 2.4% | 16 |
|
|
2016
Q1 | $39.4M | Buy |
+478,287
| New | +$39.4M | 4.04% | 8 |
|
|
2015
Q4 | – | Sell |
-368,775
| Closed | -$38.8M | – | 57 |
|
|
2015
Q3 | $38.8M | Buy |
368,775
+161,031
| +78% | +$17M | 2.94% | 15 |
|
|
2015
Q2 | $28.4M | Buy |
+207,744
| New | +$28.4M | 2.33% | 14 |
|
|
2014
Q4 | – | Sell |
-177,079
| Closed | -$12.8M | – | 57 |
|
|
2014
Q3 | $12.8M | Sell |
177,079
-291,021
| -62% | -$21M | 1.48% | 30 |
|
|
2014
Q2 | $29.1M | Buy |
+468,100
| New | +$29.1M | 3.53% | 9 |
|